Cadila Healthcare Ltd is quoting at Rs 236.95, down 2.45% on the day as on 13:24 IST on the NSE. The stock tumbled 42.06% in last one year as compared to a 9.13% rally in NIFTY and a 13.74% fall in the Nifty Pharma index.
French pharmaceutical firm Sanofi said Tuesday it is partnering with Google to use artificial intelligence and deep analytics tools to sift through its data to find better treatments. The titan in online search "will apply technology and analytics on Sanofi's large real world database to better understand what treatments work for patients," the pharmaceutical firm said in a statement. The use of Google's tools for deep analytics -- organising large amounts of data to make insights -- will help it better understand key diseases and patient outcomes to make further improvements. Sanofi will also be moving some of its business applications to Google's cloud computing platform and use artificial intelligence to improve operations. "Combining Sanofi's biologic innovations and scientific data with Google's industry-leading capabilities, from cloud computing to state-of-the-art artificial intelligence, we aspire to give people more control over their health and accelerate the discovery of ..
GlaxoSmithKline and its agency McCann Health broke the dry spell for pharma winners at Lions Health, picking up the first Grand Prix since 2016. The winning entry? A smartphone app that measures lung capacity, released in China—a market where COPD diagnosis is lagging.
Thousands of cities and counties have sued opioid drugmakers and distributors for an alleged role in a nationwide epidemic, and now lawyers for the plaintiffs have pitched a novel process to aid settlement talks.
When AstraZeneca ended a late-stage trial for Calquence early after seeing promising results, the news boded well for the drug's chances in previously treated chronic lymphocytic leukemia. Now, the drugmaker has unveiled the detailed data it plans to take before regulators later this year.